What does specialty diagnostics — cost of revenues mean?

The direct costs attributable to the production and delivery of diagnostic products and services within the Specialty Diagnostics segment. This includes raw materials, manufacturing labor, and direct overhead required to generate the segment's revenue.

Thermo Fisher Scientific (TMO) Specialty Diagnostics — Cost of revenues

Screener

Other segment segments

Laboratory Products and Biopharma Services

$4.76B+7.9%

Life Sciences Solutions

$1B+17.4%

Analytical Instruments

$876M+4.9%

Similar metrics at other companies

APGSpecialty Services — Cost of revenues

$476M+26.3%

BCOEurope — Cost of revenues

$284M+12.8%

QCOMQCT — Cost of revenues

-$4.45B+1.0%

QCOMQSI — Cost of revenues

$0-100%

DFHHomebuilding — Cost of revenues

$715.64M-8.7%

BCORest of World — Cost of revenues

$151.7M+6.9%

Other financials

Income statement

See full

Revenue$12.0B—

Operating income$2.1B—

Net income$1.7B+7.4%

EPS (diluted)$4.68+9.3%

Balance sheet

See full

Cash & equivalents$4.1B-11.7%

Total debt$39.2B+4.6%

Total equity$52.7B+4.3%

Total assets$113.17B+11.8%

Cash flow

See full

Operating cash flow$2.1B+51.9%

CapEx-$1.2B-509%

Free cash flow$923.0M-16.5%

Valuation

See full

Market cap$213.42B+21.1%

Enterprise value$248.54B+18.9%

P/E30.6×+3.9×

P/S4.8×-0.9×

Profitability

See full

Gross margin58.3%—

Operating margin17.2%+0.8pp

Net margin15.2%+1.0pp

FCF margin15.7%-2.1pp

Returns & leverage

See full

Return on equity13.5%+0.1pp

Debt / equity0.7×0.0×

Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 11:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000097745-26-000092

(In millions)	Life Sciences Solutions	Analytical Instruments	Specialty Diagnostics	Laboratory Products and Biopharma Services	Total
Elimination of intersegment revenues					(524)
Consolidated revenues					$11,005
Segment Income
Cost of revenues	1,004	876	657	4,757
Selling, general, and administrative expenses	496	313	177	597
Research and development expenses	131	139	44	15
Other segment items	50	34	(49)	(110)
Segment income	954	355	313	778	2,399

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's specialty diagnostics — cost of revenues?: Thermo Fisher Scientific (TMO) reported specialty diagnostics — cost of revenues of $657M in Q1 2026.
How has Thermo Fisher Scientific's specialty diagnostics — cost of revenues changed year-over-year?: Thermo Fisher Scientific's specialty diagnostics — cost of revenues decreased by 3.2% year-over-year, from $679M to $657M.
What does specialty diagnostics — cost of revenues mean?: The direct costs attributable to the production and delivery of diagnostic products and services within the Specialty Diagnostics segment. This includes raw materials, manufacturing labor, and direct overhead required to generate the segment's revenue.